Heineken advises UK pubs to prepare for GLP-1 users

Heineken has advised UK pubs and bars to prepare for customers using GLP-1 weight-loss medicines to order fewer alcoholic drinks, warning that the trend could reduce visits and spending. A company presentation sent to hospitality customers in October suggested venues promote half-pints, low- and no-alcohol drinks, and small plates alongside drinks. The presentation said the medicines may suppress the desire to drink and contribute to customers feeling full, resulting in fewer servings. Heineken warned that traditional occasions involving multiple pints could become less common as GLP-1 use grows. Its advice was framed as a possible commercial risk, not as evidence that the medicines have already caused a fall in UK pub sales. Heineken said it has observed changes in consumption among GLP-1 users and will monitor how their behavior evolves in 2027. The company described users as choosing smaller servings, lower-alcohol drinks and more premium products, while saying those patterns also reflect wider consumer interest in moderation and wellbeing. It said the presentation was part of its regular engagement with UK hospitality businesses. Evidence about drinking behavior does not...